Online health and wellness company Hims & Hers reported fourth-quarter earnings that beat Wall Street analysts' expectations ...

Novo Nordisk is committed to the responsible use of our semaglutide-containing medicines which represent distinct products with different indications, dosages, prescribing information, titration ...

Ozempic, along with its sister drug Wegovy ... Typically, a responsible doctor approaches prescriptions with a titration mindset: starting at a low dose and slowly increasing it to find the ...

The new authorisation has been granted for a single-dose, pre-filled pen device that requires no titration and is approved ... and also claim that its current Ozempic shows the greater levels ...

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration’s (FDA) drug shortage list ...

Semaglutide — the powerful ingredient behind Wegovy and Ozempic — has long been hailed a monumental breakthrough in the war on obesity and type 2 diabetes. But American doctors, who tracked ...

Shares of wellness-product platform Hims & Hers Health Inc. tumbled on Friday after the Food and Drug Administration said the shortage of GLP-1 medications like Ozempic and Wegovy had been ...

It comes after the star revealed that taking weight-loss drugs, like Ozempic and Wegovy, helped her realize the truth about 'thin people.' In 2023, Oprah finally admitted to using an undisclosed ...

PLAINSBORO, N.J., Feb. 21, 2025 /PRNewswire/ -- Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has determined the shortage of Wegovy ® and Ozempic ® is resolved.